We are live on ! Find out more
AP

Antipodes Partners Portfolio holdings

AUM $5.19B
1-Year Est. Return 36.17%
This Fund
S&P 500
This Quarter Est. Return
+8.19%
1 Year Est. Return
+36.17%
3 Year Est. Return
+104%
5 Year Est. Return
+169.34%
10 Year Est. Return
AUM
$2.9B
AUM Growth
+$11.3M
Cap. Flow
-$150M
Cap. Flow %
-5.17%
Top 10 Hldgs %
47.84%
Holding
82
New
13
Increased
19
Reduced
33
Closed
13

Top Sells

Rank Stock Value
1
WBA
Walgreens Boots Alliance
WBA
+$114M
2
GILD icon
Gilead Sciences
GILD
+$99.9M
3
HAL icon
Halliburton
HAL
+$71.2M
4
STX icon
Seagate
STX
+$71.1M
5
TMUS icon
T-Mobile US
TMUS
+$51.5M

Sector Composition

Rank Sector Weight
1 Technology 22.53%
2 Consumer Discretionary 15.2%
3 Healthcare 14.36%
4 Communication Services 14.16%
5 Financials 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETN icon
51
Eaton
ETN
$150B
$77K ﹤0.01%
384
NU icon
52
Nu Holdings
NU
$70B
$76K ﹤0.01%
9,637
-6,514
-40% -$40K
CZR icon
53
Caesars Entertainment
CZR
$6.03B
$66K ﹤0.01%
1,300
-125
-9% -$5.68K
MP icon
54
MP Materials
MP
$7.42B
$40K ﹤0.01%
1,790
+703
+65% +$16.1K
CRDO icon
55
Credo Technology Group
CRDO
$37.5B
$39K ﹤0.01%
2,261
AMPS
56
DELISTED
Altus Power
AMPS
$35K ﹤0.01%
6,504
+901
+16% +$4.45K
APTV icon
57
Aptiv
APTV
$12.3B
$30K ﹤0.01%
296
+40
+16% +$3.96K
DO
58
DELISTED
Diamond Offshore Drilling, Inc.
DO
$29K ﹤0.01%
+2,067
New +$24.5K
LUMN icon
59
Lumen
LUMN
$6.76B
$28K ﹤0.01%
+12,395
New +$27.3K
HSIC icon
60
Henry Schein
HSIC
$9.7B
$25K ﹤0.01%
316
-104
-25% -$8.22K
ARGX icon
61
argenx
ARGX
$54.6B
$22K ﹤0.01%
59
ALNY icon
62
Alnylam Pharmaceuticals
ALNY
$27.4B
$10K ﹤0.01%
56
-84
-60% -$16.7K
WLK icon
63
Westlake Corp
WLK
$9.19B
$6K ﹤0.01%
56
-15
-21% -$1.72K
GXO icon
64
GXO Logistics
GXO
$5.8B
$5K ﹤0.01%
84
-334
-80% -$18.7K
NEX
65
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$4K ﹤0.01%
510
-3,469
-87% -$28.6K
EQT icon
66
EQT Corp
EQT
$33B
$1K ﹤0.01%
35
-522
-94% -$18.5K
DADA
67
DELISTED
Dada Nexus
DADA
-8,388
Closed -$71K
FRO icon
68
Frontline
FRO
$8.7B
-2,012
Closed -$33K
GDS icon
69
GDS Holdings
GDS
$6.41B
-3,102
Closed -$57K
GILD icon
70
Gilead Sciences
GILD
$163B
-1,204,538
Closed -$99.9M
JD icon
71
JD.com
JD
$43.6B
-698,181
Closed -$30.6M
LMT icon
72
Lockheed Martin
LMT
$132B
-819
Closed -$387K
NOC icon
73
Northrop Grumman
NOC
$76B
-85,744
Closed -$39.6M
PATH icon
74
UiPath
PATH
$6.41B
-1,459
Closed -$25K
TMUS icon
75
T-Mobile US
TMUS
$186B
-355,630
Closed -$51.5M

Similar funds

Antipodes Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Antipodes Partners held 82 positions worth $2.9B, up 0.39% from $2.89B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Antipodes Partners withdrew a net $150M in Q2 2023, closing 13 positions and reducing 33 holdings. Its most notable exit was Walgreens Boots Alliance, an estimated $114M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Antipodes Partners opened a new position in Amazon worth $124M.

  • Antipodes Partners's largest Q2 2023 buy was Amazon: 949,169 shares worth $124M.
  • Antipodes Partners added most to American Electric Power in Q2 2023, an estimated $51.1M increase.
  • Antipodes Partners's biggest Q2 2023 reduction was Halliburton, cutting an estimated $71.2M.
  • Antipodes Partners fully exited Walgreens Boots Alliance in Q2 2023, selling an estimated $114M.
  • Antipodes Partners's ten largest holdings make up 48% of its $2.9B portfolio in Q2 2023.
  • Antipodes Partners opened 13 new positions and closed 13 in Q2 2023.
  • Antipodes Partners's portfolio value rose 0.39% quarter-over-quarter to $2.9B.

Based on Antipodes Partners's 13F filing for Q2 2023, filed 25 Jul 2023.